Programme Description
The joint fellowship between ECTRIMS and the MOGAD Eugene Devic European Network (MEDEN) aims to foster collaboration and research among clinicians and scientists across Europe, focusing on neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte antibody associated disorder (MOGAD). This fellowship programme will enable the awarded applicant to gain research experience either in a priority project at one of six MEDEN network sites, or on a separate project as proposed by the applicant.
The MEDEN Committee will accept proposals for 1-year fellowships, either based on a priority research theme or on one of the 4 themed working groups within MEDEN (clinical, biomarkers, treatment, pregnancy), ensuring that research efforts align with the most urgent needs in the specialty. A jury, consisting of MEDEN leaders and an ECTRIMS representative, will select the fellowship recipient after a thorough review of applications.
This new joint fellowship effort is made possible in part by contributions from The Sumaira Foundation and Alexion AstraZeneca Rare Disease.
The application cycle for the 2027 programme will open in August 2026.
This joint fellowship is supported by The Sumaira Foundation and Alexion AstraZeneca Rare Disease. ECTRIMS initiatives are funded in part by financial contributions from industry and NPO partners. Contact secretariat@ectrims.eu for information about how to support this or other initiatives.